Eleftheria Galatou
University of Nicosia(CY)
Publications by Year
Research Areas
Cardiac Ischemia and Reperfusion, Cardiovascular Function and Risk Factors, Peroxisome Proliferator-Activated Receptors, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action(2021)127 cited
- → Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy(2018)69 cited
- → PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia–reperfusion injury: involvement of PI3K–Akt(2012)55 cited
- → Role of Pleiotropic Properties of Peroxisome Proliferator‐Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection(2015)39 cited
- → Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production(2021)32 cited
- → Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection(2024)29 cited
- → The role of PPAR in myocardial response to ischemia in normal and diseased heart(2011)27 cited
- → Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes(2011)24 cited
- → Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine(2022)24 cited
- → Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia–reperfusion(2013)22 cited